Clinical Trial Update: The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of REX-001 for ischemic rest pain in patients with critical limb ischemia and diabetes; the study has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia
• Diabetes Mellitus
• Peripheral Arterial Disease

Drugs mentioned

• REX-001

Snippet

Sponsor: Ixaka Ltd | Conditions: Peripheral Arterial Disease (PAD), Diabetes Mellitus (DM) | Phase 3 | Status: TERMINATED